当前位置:首页 - 行情中心 - 药明康德(603259) - 财务分析 - 现金流量表

药明康德

(603259)

93.65

-3.22  (-3.32%)

今开:97.39最高:98.62成交:7.19万手 市盈:0.00 上证指数:3043.03   -1.97%2019-03-25
昨收:96.87 最低:93.60 换手:0.00%振幅:0.00 深证指数:9701.70  -1.80%15:31:29

集合

竞价

现金流量表

按照会计年度查询:
报告期2018-12-312018-09-302018-06-302018-03-31
一、经营活动产生的现金流量
销售商品、提供劳务收到的现金9,269,734,027.476,587,023,633.524,296,120,940.042,245,083,411.06
收到的税费返还297,228,154.12189,473,959.8173,351,749.3881,292,196.92
收到其他与经营活动有关的现金261,250,599.3893,820,090.864,909,288.7752,648,444.43
经营活动现金流入小计9,828,212,780.976,870,317,684.124,534,381,978.192,379,024,052.41
购买商品、接受劳务支付的现金3,858,240,969.912,687,566,6621,667,250,753.44660,386,301.11
支付给职工以及为职工支付的现金2,778,229,440.81,974,299,324.791,479,406,657.841,072,411,813.19
支付的各项税费488,048,753.77594,051,817.5499,621,809.15258,799,119.9
支付其他与经营活动有关的现金1,063,265,852.49697,100,849.33389,845,986.05419,118,757.49
经营活动现金流出小计8,187,785,016.975,953,018,653.624,036,125,206.482,410,715,991.68
经营活动产生的现金流量净额1,640,427,764917,299,030.5498,256,771.71-31,691,939.27
二、投资活动产生的现金流量
收回投资收到的现金79,949,369.0379,845,809.7679,845,809.76128,042,973.29
取得投资收益收到的现金104,855,338.7476,376,356.8525,587,529.158,456,729.62
处置固定资产、无形资产和其他长期
资产收回的现金净额
9,468,759.563,562,073.453,188,560.951,747,023.27
处置子公司及其他营业单位收到的现金净额23,788,656.823,788,656.8----
收到其他与投资活动有关的现金----5,431,7001,331,700
投资活动现金流入小计218,062,124.13183,572,896.86114,053,599.86139,578,426.18
购建固定资产、无形资产和其他长期资产支付的现金2,248,894,565.091,278,961,303.93844,763,707.37397,940,977.07
投资支付的现金3,122,107,938.423,494,809,562.743,033,204,711.68693,198,765.7
取得子公司及其他营业单位支付的现金净额123,721,526.13------
支付其他与投资活动有关的现金--------
投资活动现金流出小计5,494,724,029.644,773,770,866.673,877,968,419.051,091,139,742.76
投资活动产生的现金流量净额-5,276,661,905.51-4,590,197,969.81-3,763,914,819.19-951,561,316.58
三、筹资活动产生的现金流量
吸收投资收到的现金--------
子公司吸收少数股东投资收到的现金--------
取得借款收到的现金1,465,529,6001,333,197,600833,744,633.03633,248,474.01
收到其他与筹资活动有关的现金--25,863,619----
发行债券收到的现金--------
筹资活动现金流入小计10,717,593,212.643,519,722,476.222,994,405,890.25633,248,474.01
偿还债务支付的现金2,983,584,0001,068,165,000700,547,033.03394,865,296.79
分配股利、利润或偿付利息支付的现金102,552,721.1979,131,436.256,767,016.6317,277,911.62
子公司支付给少数股东的股利--------
支付其他与筹资活动有关的现金647,296,932.65248,520,107.247,714,792.12--
筹资活动现金流出小计3,733,433,653.841,395,816,543.4805,028,841.78412,143,208.41
筹资活动产生的现金流量净额6,984,159,558.82,123,905,932.822,189,377,048.47221,105,265.6
四、现金及现金等价物净增加额
汇率变动对现金的影响-56,378,440.566,488,535.29-9,507,706.7822,221,297.12
现金及现金等价物净增加额3,291,546,976.73-1,542,504,471.2-1,085,788,705.79-739,926,693.13
期初现金及现金等价物余额2,466,143,803.492,466,143,803.492,466,143,803.492,472,390,524.24
期末现金及现金等价物余额5,757,690,780.22923,639,332.291,380,355,097.71,732,463,831.11
补充资料:
1、将净利润调节为经营活动的现金流量:
净利润2,333,680,728.3--1,304,069,675.5--
加:资产减值准备12,532,209.46---7,019,588.51--
固定资产折旧、油气资产折耗、生产性生物资产折旧500,660,015.28--231,917,397.83--
无形资产摊销43,745,158.22--23,045,721.65--
长期待摊费用摊销105,358,186.17--44,168,003.23--
待摊费用减少--------
预提费用增加--------
处置固定资产、无形资产和其他长期资产的损失-1,331,537.06--2,592,222.92--
固定资产报废损失11,704,636------
公允价值变动损失-606,436,803.99---381,452,524.66--
财务费用110,746,696.78--47,128,009.91--
投资损失-79,636,460.57---59,609,150.73--
递延所得税资产减少-6,016,295.8---17,877,257.86--
递延所得税负债增加8,466,658.97---14,318,206.69--
存货的减少-226,236,595.24---112,295,510.01--
经营性应收项目的减少-938,082,822.54---59,532,131.16--
经营性应付项目的增加327,282,412.29---500,254,809.58--
未确认的投资损失--------
其他43,991,577.73---2,305,080.13--
经营活动产生的现金流量净额1,640,427,764--498,256,771.71--
2、债务转为资本--------
3、一年内到期的可转换公司债券--------
4、融资租入固定资产--------
5、现金及现金等价物净增加情况:
现金的期末余额5,757,690,780.22--1,380,355,097.7--
减:现金的期初余额2,466,143,803.49--2,466,143,803.49--
现金等价物的期末余额--------
减:现金等价物的期初余额--------
现金及现金等价物净增加额3,291,546,976.73---1,085,788,705.79--
TOP↑